Vaccines: Expert Consult - Online and Print
Autor Stanley A. Plotkin, Walter Orenstein, Paul A. Offiten Limba Engleză Hardback – 11 oct 2012
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you'll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
Preț: 1545.43 lei
Preț vechi: 1966.47 lei
-21% Nou
Puncte Express: 2318
Preț estimativ în valută:
295.76€ • 307.22$ • 245.67£
295.76€ • 307.22$ • 245.67£
Carte disponibilă
Livrare economică 17-29 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781455700905
ISBN-10: 1455700908
Pagini: 1570
Ilustrații: Approx. 600 illustrations (600 in full color)
Dimensiuni: 276 x 219 x 79 mm
Greutate: 5.06 kg
Ediția:6th revised edition. Expert Consult.
Editura: Elsevier
ISBN-10: 1455700908
Pagini: 1570
Ilustrații: Approx. 600 illustrations (600 in full color)
Dimensiuni: 276 x 219 x 79 mm
Greutate: 5.06 kg
Ediția:6th revised edition. Expert Consult.
Editura: Elsevier
V-ar putea interesa
-
Research on Health Effects of Low-Level Ionizing Radiation Exposure: Opportunities for the Armed Forces Radiobiology Research InstituteCommittee on Research Directions in Huma-5%Preț: 262.11 lei275.91 lei -
The Influence of Global Environmental Change on Infectious Disease Dynamics: Workshop SummaryForum on Microbial Threats-5%Preț: 466.56 lei491.12 lei -
Plotkin's VaccinesWalter A. Orenstein-24%Preț: 1677.35 lei2200.01 lei -
Preț: 102.19 lei -
The Prevention of Tuberculosis (Routledge Revivals)Sir Arthur Newsholme-26%Preț: 1044.61 lei1406.37 lei -
Pandora's Lab: Seven Stories of Science Gone WrongPaul A. OffitPreț: 140.02 lei -
General Book on Infectious DiseasesVenkataramana Rolla-5%Preț: 197.47 lei207.87 lei -
The Ebola Outbreak in West AfricaPhd Constantine N. Nana-5%Preț: 84.60 lei89.05 lei -
The Compendium of Infection Control Technologies Workbook IntroductionJoel Stephen Rossen DVM-5%Preț: 48.88 lei51.45 lei -
The Compendium of Infection Control TechnologiesJoel S. Rossen-5%Preț: 260.51 lei274.22 lei -
Compendium of Infection Control TechnologiesJoel S. Rossen-5%Preț: 182.36 lei191.96 lei -
Book 4 Compendium of Infection Control Technologies WorkbookJoel S. Rossen-5%Preț: 259.30 lei272.95 lei -
History of Vaccine DevelopmentStanley A. Plotkin-5%Preț: 1879.12 lei1978.02 lei -
The Global Challenge of HIV/AIDS, Tuberculosis, and MalariaAlexandra E. Kendall-5%Preț: 92.76 lei97.64 lei -
-5%Preț: 973.37 lei1024.60 lei -
Polio & Pps Besser VerstehenTom House-5%Preț: 113.32 lei119.28 lei -
EbolaVarious-5%Preț: 192.78 lei202.92 lei -
Infectious DiseaseJt Thomas MD-5%Preț: 150.62 lei158.55 lei -
Insight in Medical Microbiology & ParasitologyMuhamed T. Osman-5%Preț: 151.97 lei159.97 lei -
Zika VirusMary Bradley-Cox-5%Preț: 38.82 lei40.87 lei -
Mass Vaccination: Global Aspects - Progress and ObstaclesStanley A. Plotkin-5%Preț: 1071.71 lei1128.12 lei -
-5%Preț: 383.45 lei403.63 lei -
-5%Preț: 1370.47 lei1442.60 lei
Cuprins
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508